Photo: Imperial College London website. Imperial is partnering with biotechnology company EnteroBiotix on research into the potential of therapies based on the gut bacterial community.
/PRNewswire/ EnteroBiotix Limited ("EBX"), a premier, full-spectrum microbiome therapeutics company, today announced a partnership with Imperial College.